|Cardiovascular Health Announcements|
April 24, 2017
2017 Million Hearts® Hypertension Control Challenge
April 19, 2017
Advancing Team-Based Care Through the Use of Collaborative Practice Agreements and Using the Pharmacists’ Patient Care Process to Manage High Blood Pressure
NACDD, in coordination with CDC’s Division for Heart Disease and Stroke Prevention, is pleased to announce that state teams from Arizona, Georgia, Iowa, Utah, Virginia, West Virginia and Wyoming will participate in a learning program that is designed to accelerate team-based care using the pharmacists’ patient care process (PPCP) and collaborative practice agreements (CPA) designed to manage high blood pressure. The state health department and pharmacy partner teams will attend an in-person workshop on May 24-25, 2017 in Atlanta, GA and several follow up webinars to acquire the information needed to host trainings within their states for pharmacists and primary care physicians. The teams will be expected to develop a project plan and timeline for disseminating and supporting pharmacists with implementing the PPCP and CPA resource guides provided by the CDC.
Lessons learned from this project will be disseminated during a fireside chat in September 2017. Please visit http://www.chronicdisease.org/general/custom.asp?page=PPCPandPCAProject for more information about the state teams and the resources that they will be using.
April 14, 2017
NACDD Helps to Shape Agenda for Cholesterol Control
On April 11, 2017, several members of NACDD’s leadership, Cardiovascular Health Team, and members from the Texas Department of State Health Services were selected to participate in a multi-disciplinary planning session to help shape the future of cholesterol control. This innovative meeting was hosted by the American Heart Association/American Stroke Association in Dallas, TX and included Janet Wright of Million Hearts, and leaders in healthcare and academia, along with several patients. Experts in the field held a series of presentations and panel discussions to share their insights on barriers to cholesterol management including communication barriers, and treatment and lifestyle compliance. The NACDD team helped to develop and then electronically vote on tangible, actionable strategies that the AHA and all the organizations should prioritize to advance evidence-based diagnosis, treatment and long-term management of cholesterol. The Cholesterol Summit was co-led by Dr. Eduardo Sanchez, Chief Prevention and Medical Officer at AHA and Dr. Mary Ann Bauman, a member of the American Heart Association/American Stroke Association Cholesterol Advisory Group.
1305/1422 Epidemiology and Evaluation Collaborative (EEC) Celebrates 100 State Members!
NACDD’s peer learning group for epidemiology, surveillance, and evaluation staff in 1305 and 1422 programs has ballooned in the last year, with the current participation list at 100 members. Funded through the Division for Heart Disease and Stroke Prevention’s Program Development and Services Branch, monthly meetings with active discussion now average over 50 participants. Current topics on evaluation and performance measures drive the agendas, and the meetings are facilitated by members. Brittany Brown (UT), Liz Gebhart (NE), and Paul Meddaugh (VT) comprise the EEC Leadership and help to plan meeting agendas. Between meetings, EEC members connect by email to share resources, such as assessment tools, strategies for calculating performance measures, and to clarify CDC guidance. States often receive responses from several states within a few days and sometimes within a matter of hours.
A factor contributing to EEC’s success is the regular participation of CDC 1305 staff on EEC calls. The Division for Heart Disease and Stroke Prevention’s Applied Research and Evaluation Branch (AREB) leads evaluation for 1305. The 1305 and 1422 lead evaluators attend EEC calls, where they can provide immediate answers to questions and updates on forthcoming resources and deadlines. CDC’s Epidemiology and Surveillance Branch also sends a representative to meetings to help the branch stay informed of ongoing surveillance and epidemiology needs in states.
Outgoing Chair Rachael Austin (NY) explained how EEC has shaped her work as an epidemiologist and evaluator:
When CDC released the 1305 FOA in 2013, I found myself transitioning from the role of a diabetes epidemiologist to the lead epi/evaluator for all of New York’s D3/D4 activities. I had no idea where to start, and the idea of health systems work overwhelmed me. Luckily, our HDSP program manager at the time suggested that I join EEC to connect with other evaluators in the field. That remains one of the best pieces of advice I’ve ever received. EEC became somewhat of a home for me– a safe place to discuss barriers and challenges to data collection and reporting, share tools and resources and develop solutions to common questions/issues. It also allowed me to network and develop friendships with my peers from all over the country…I recommend EEC participation to all of our new New York State staff working on 1422 and 1305. There has been no better venue to collaborate, learn and share best practices with other chronic disease epi/evals than EEC.”
EEC meets on the second Wednesday of the month at 2pm ET. Meetings are open to anyone interested in 1305/1422 data discussions. For more information about EEC, visit our webpage and contact MaryCatherine Jones, Public Health Consultant, at email@example.com.